Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG)

被引：0
|
作者：
Gururangan, S [1 ]
Allen, JC [1 ]
Phillips, PC [1 ]
Dillard, E [1 ]
Friedman, HS [1 ]
机构：
[1] Duke Univ, Med Ctr, Brain Tumor Ctr, Durham, NC USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [1] Phase II study of carboplatin in children with progressive low-grade gliomas
    Gururangan, S
    Cavazos, CM
    Ashley, D
    Herndon, JE
    Bruggers, CS
    Moghrabi, A
    Scarcella, DL
    Watral, M
    Tourt-Uhlig, S
    Reardon, D
    Friedman, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (13) : 2951 - 2958
  • [2] Progressive low-grade oligodendroglioma: Treatment results with temozolomide (TMZ)
    Levin, N
    Linetsky, E
    Siegal, T
    NEUROLOGY, 2004, 62 (07) : A544 - A544
  • [3] Phase II study of prolonged daily temozolomide for low-grade gliomas in adults
    Kesari, Santosh
    Schiff, David
    Drappatz, Jan
    Gigas, Debra
    Doherty, Lisa
    Ligon, Keith
    Muzikansky, Alona
    Ciampa, Abgail
    Bradshaw, Joanna
    Levy, Brenda
    Radakovic, Gospova
    Ramakrishna, Naren
    Black, Peter
    Wen, Patrick
    NEURO-ONCOLOGY, 2007, 9 (04) : 522 - 522
  • [4] Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults
    Kesari, Santosh
    Schiff, David
    Drappatz, Jan
    LaFrankie, Debra
    Doherty, Lisa
    Macklin, Eric A.
    Muzikansky, Alona
    Santagata, Sandro
    Ligon, Keith L.
    Norden, Andrew D.
    Ciampa, Abigail
    Bradshaw, Joanna
    Levy, Brenda
    Radakovic, Gospova
    Ramakrishna, Naren
    Black, Peter M.
    Wen, Patrick Y.
    CLINICAL CANCER RESEARCH, 2009, 15 (01) : 330 - 337
  • [5] PHASE I/II STUDY OF TARCEVA/RAPAMYCIN FOR RECURRENT PEDIATRIC LOW-GRADE GLIOMAS (LGG)
    Packer, R. J.
    Yalon, M.
    Rood, B. R.
    Chao, M.
    Miller, M. M.
    McCowage, G.
    Vezina, G.
    NEURO-ONCOLOGY, 2010, 12 (06) : II20 - II20
  • [6] Temozolomide (TMZ) 3 weeks on/1 week off in the treatment of progressive low grade gliomas: A phase II GICNO study.
    Brandes, A. A.
    Tosoni, A.
    Cavallo, G.
    Scopece, L.
    Gardiman, M.
    Berti, F.
    Pasetto, L. M.
    Ferrarese, F.
    Blatt, V.
    Ermani, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 61S - 61S
  • [7] Temozolomide in children with progressive low-grade glioma
    Gururangan, Sridharan
    Fisher, Michael J.
    Allen, Jeffrey C.
    Herndon, James E., II
    Quinn, Jennifer A.
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Phillips, Peter C.
    Watral, Melody A.
    Krauser, Jeanne M.
    Friedman, Allan H.
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2007, 9 (02) : 161 - 168
  • [8] Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas
    Kuo, DJ
    Weiner, HL
    Wisoff, J
    Miller, DC
    Knopp, EA
    Finlay, JL
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (05) : 372 - 378
  • [9] A MULTI-INSTITUTIONAL PHASE II STUDY OF VINORELBINE IN CHILDREN WITH RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMAS
    Hwang, Eugene
    Mun, Alissa
    Kilburn, Lindsay
    Chi, Susan
    Knipstein, Jeffrey
    Oren, Michal
    Dvir, Rina
    Hardy, Kristina
    Rood, Brian
    Packer, Roger
    NEURO-ONCOLOGY, 2014, 16 : 62 - 62
  • [10] Phase II trial of temozolomide in patients with progressive low-grade glioma
    Quinn, JA
    Reardon, DA
    Friedman, AH
    Rich, JN
    Sampson, JH
    Provenzale, JM
    McLendon, RE
    Gururangan, S
    Bigner, DD
    Herndon, JE
    Avgeropoulos, N
    Finlay, J
    Tourt-Uhlig, S
    Affronti, ML
    Evans, B
    Stafford-Fox, V
    Zaknoen, S
    Friedman, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 646 - 651
12345